Stock listing

ASX:EBR EBR Systems, Inc. Share Price

Home listing (ASX) of EBR Systems, Inc.

Follow EBR Systems, Inc. into a list and get an email when it puts out news.

Share price · ASX:EBR

$0.16 AUD +0.01 (+6.7%)

Close on Nov 20, 2026

Past year -85.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.155 – $0.185 AUDNov 20, 2026
Volume
2.75M sharesNov 20, 2026
Market cap
$120.5M AUDAt the close on Nov 20, 2026 · price × 753.4M shares outstanding
52-week range
$0.105 – $1.14 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$421,837 AUDMedian day 1.56M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
EBR Systems, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:EBR · Home$0.16 AUD+0.01 (+6.7%)2,751,147$0.155$0.185$0.155$0.15Close on Nov 20, 2026
OTC:EBRCZ$0.083 USD0.000 (0.0%)—$0.083$0.083$0.083$0.083Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:EBR · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.16+0.01+6.7%$0.155$0.185$0.1552,751,147
$0.15-0.015-9.1%$0.165$0.165$0.1451,501,310
$0.165+0.01+6.5%$0.155$0.165$0.155448,287
$0.1550.000.0%$0.155$0.16$0.155761,200
$0.155-0.015-8.8%$0.17$0.175$0.1552,623,054
$0.170.000.0%$0.165$0.185$0.163,397,037
$0.17+0.005+3.0%$0.16$0.17$0.1552,969,766
$0.165+0.03+22.2%$0.14$0.165$0.143,407,551
$0.135+0.01+8.0%$0.13$0.15$0.134,729,061
$0.125+0.005+4.2%$0.12$0.125$0.1151,329,132
$0.12+0.01+9.1%$0.11$0.125$0.1053,484,136
$0.11-0.005-4.3%$0.12$0.12$0.111,493,021
$0.1150.000.0%$0.115$0.12$0.111,484,533
$0.115-0.015-11.5%$0.125$0.13$0.1151,520,940
$0.13+0.01+8.3%$0.125$0.135$0.121,776,431
$0.12-0.01-7.7%$0.125$0.135$0.122,077,998
$0.13+0.005+4.0%$0.125$0.13$0.121,088,324
$0.125-0.01-7.4%$0.14$0.14$0.122,274,784
$0.1350.000.0%$0.14$0.14$0.131,113,821
$0.135-0.005-3.6%$0.145$0.148$0.1351,743,090
$0.14-0.005-3.4%$0.145$0.145$0.14824,141
$0.145-0.005-3.3%$0.15$0.15$0.145284,868
$0.15+0.005+3.4%$0.15$0.165$0.152,282,970
$0.145+0.005+3.6%$0.145$0.15$0.141,365,863
$0.140.000.0%$0.145$0.145$0.141,178,349
$0.14-0.015-9.7%$0.155$0.155$0.142,410,309
$0.1550.000.0%$0.165$0.165$0.1553,767,496
$0.155+0.015+10.7%$0.14$0.165$0.147,115,658
$0.14-0.095-40.4%$0.22$0.22$0.1327,915,201
$0.235+0.005+2.2%$0.235$0.245$0.2351,298,389
$0.23-0.015-6.1%$0.245$0.25$0.231,893,989
$0.245-0.005-2.0%$0.255$0.255$0.245988,310
$0.250.000.0%$0.26$0.26$0.25816,498
$0.25-0.01-3.8%$0.26$0.263$0.251,049,341
$0.26-0.02-7.1%$0.275$0.275$0.26446,435
$0.280.000.0%$0.28$0.28$0.282,385,886
$0.28+0.02+7.7%$0.26$0.29$0.261,335,612
$0.26+0.02+8.3%$0.25$0.27$0.251,860,092
$0.24-0.005-2.0%$0.25$0.255$0.24878,100
$0.245-0.005-2.0%$0.255$0.26$0.245805,328
$0.25-0.015-5.7%$0.263$0.265$0.251,609,453
$0.2650.000.0%$0.265$0.27$0.26671,202
$0.2650.000.0%$0.265$0.265$0.255937,773
$0.265+0.005+1.9%$0.275$0.275$0.261,074,074
$0.26+0.015+6.1%$0.255$0.275$0.25734,833
$0.2450.000.0%$0.245$0.255$0.243,554,271
$0.2450.000.0%$0.25$0.25$0.2351,929,332
$0.245-0.015-5.8%$0.255$0.26$0.2452,004,239
$0.26+0.005+2.0%$0.26$0.26$0.251,544,565
$0.255-0.02-7.3%$0.27$0.27$0.252,850,059
$0.275-0.02-6.8%$0.29$0.29$0.2751,851,437
$0.295-0.005-1.7%$0.295$0.295$0.2852,124,924
$0.30+0.015+5.3%$0.295$0.30$0.2851,081,887
$0.285+0.005+1.8%$0.285$0.31$0.2852,512,184
$0.280.000.0%$0.28$0.29$0.28575,867
$0.280.000.0%$0.28$0.285$0.275276,554
$0.28-0.005-1.8%$0.285$0.285$0.271,327,220
$0.285+0.01+3.6%$0.28$0.29$0.28457,987
$0.2750.000.0%$0.275$0.285$0.271,115,100
$0.275-0.005-1.8%$0.275$0.285$0.2752,561,245
$0.28-0.015-5.1%$0.295$0.295$0.28889,934
$0.295-0.01-3.3%$0.30$0.30$0.291,577,241
$0.305+0.02+7.0%$0.285$0.305$0.281,727,046
$0.285+0.01+3.6%$0.27$0.29$0.2652,039,665
$0.275-0.01-3.5%$0.28$0.28$0.2652,656,724
$0.285+0.01+3.6%$0.275$0.29$0.2753,038,239
Ticker
ASX:EBR
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Change of Director's Interest Notice

Nov 15, 2026

Closed $0.155 (0.0%) on Nov 16, 2026

Investor Webinar - Updated

Nov 9, 2026

Closed $0.165 (+22.2%) on Nov 10, 2026

Investor Webinar

Nov 9, 2026

Closed $0.165 (+22.2%) on Nov 10, 2026

EBR to Present at Canaccord Genuity Forum

Nov 2, 2026

Closed $0.115 (0.0%) on Nov 3, 2026

All EBR Systems, Inc. news

EBR Systems, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
36 in the last 12 months · 36 in all · newest Nov 19, 2026 · oldest 2026
Decks
28 decks · latest Jul 31, 2026

Where EBR Systems, Inc. is listed

ListingExchangeCountryCurrency
ASX:EBR · Home listing · This pageASXAustraliaAUD
OTC:EBRCZOTCUnited StatesUSD

Valuation

Price/book 1.0× against a median of 1.4×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$54.64M AUD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.5×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
EBR Systems, Inc. · ASX:EBRUS$79.78MUS$36.17Mn/an/an/a1.0×n/a0.5×n/a
Viromed Medical AG · XETR:VMEUS$83.96MUS$83.66M127×15.0×n/a8.1×11.9%0.0×n/a
ICARES Medicus Inc · TPEX:6612US$83.86MUS$61.27M29.6×1.7×7.3×1.5×7.7%0.0×n/a
Nyxoah SA · EURONEXT:NYXHUS$83.60MUS$6.53Mn/a0.3×n/a0.9×−443.2%0.3×n/a
Optiscan Imaging Limited · ASX:OILUS$83.05MUS$74.44Mn/a251×n/a6.6×n/a0.1×n/a
DIO Corporation · KRX:039840US$78.78MUS$59.85M4.8×0.5×3.4×0.6×12.7%0.1×n/a
Zomedica Corp. · OTC:ZOMDFUS$78.49MUS$71.21Mn/a1.8×n/a0.8×−41.3%0.0×0.10
SkinHealth Systems Inc. · NASDAQ:SKINUS$77.00MUS$228.9Mn/a0.8×8.0×1.4×−6.3%4.7×1.24
Graphy Inc. · KRX:318060US$76.80MUS$76.08Mn/a4.4×n/a6.8×−48.1%0.0×n/a
L&K BIOMED Co., Ltd. · KRX:156100US$76.55MUS$61.13M37.3×2.1×24.3×1.6×6.9%0.0×n/a
Wellell Inc. · TWSE:4106US$73.78MUS$52.11M13.1×0.7×5.4×1.0×7.4%0.1×n/a
Median of the othersUS$78.64MUS$66.24M29.6×1.8×7.3×1.4×6.9%0.1×0.67

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
0.98 AUD · Analysts' mean
EPS, year to Dec 2026
-0.11 · 2 analysts
Revenue, year to Dec 2026
10.55M · 2 analysts

Team and board

OfficerRole
John SmithCEO
Robert C. CanbyChief Medical Officer
Santa ClaraEBR announces transition of Chief Commercial Officer
Sara HardinProject Manager
Simon AdamsCTO

Events

QuarterResultsShare move
Q2 2026Aug 11, 2026 · After close+1.8%
Q1 2026May 11, 2026 · After close−12.5%
Q4 2025Mar 18, 2026 · After close+1.4%
Q3 2025Nov 12, 2025 · After close−4.2%
Q2 2025Aug 12, 2025 · After close+3.0%
Q1 2025May 13, 2025 · After close−4.2%
Q4 2024Mar 24, 2025−1.0%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings9 slidesJul 31, 2026
Investor Presentation (June 2026)Investor deck50 slidesJun 4, 2026
Shareholder Meeting (May 2026)Shareholder meeting8 slidesMay 7, 2026
Investor Presentation (March 2026)Investor deck22 slidesMar 10, 2026
Piper Sandler 37th Annual Healthcare Conference (December 2025)Conference14 slidesDec 1, 2025
Drug & Device Conference (October 2025)Conference14 slidesOct 9, 2025
HealthInvest 2025Conference13 slidesSep 22, 2025
Canaccord Growth Conference 2025Conference14 slidesAug 11, 2025
Investor Presentation (May 2025)Investor deck47 slidesMay 22, 2025
Shareholder Meeting (May 2025)Shareholder meeting10 slidesMay 22, 2025
All 28 decks
DeckKindSlidesDate
Investor Presentation (April 2025)Investor deck18 slidesApr 14, 2025
Investor Presentation (March 2025)Investor deck20 slidesMar 25, 2025
Investor Presentation (January 2025)Investor deck19 slidesJan 21, 2025
Investor Presentation (September 2024)Investor deck50 slidesSep 18, 2024
Investor Presentation (July 2024)Investor deck18 slidesJul 12, 2024
Shareholder Meeting (May 2024)Shareholder meeting9 slidesMay 30, 2024
Investor Presentation (January 2024)Investor deck20 slidesJan 30, 2024
Bell Potter Healthcare Conference 2023Conference16 slidesNov 15, 2023
Investor Presentation (June 2023)Investor deck40 slidesJun 23, 2023
Investor Presentation (May 2023)Investor deck20 slidesMay 29, 2023
Shareholder Meeting (May 2023)Shareholder meeting8 slidesMay 23, 2023
Investor Presentation (May 2023)Investor deck27 slidesMay 22, 2023
Investor Presentation (April 2023)Investor deck18 slidesApr 26, 2023
Investor Presentation (January 2023)Investor deck18 slidesJan 30, 2023
Corporate Update (October 2022)Corporate update6 slidesOct 21, 2022
Shareholder Meeting (May 2022)Shareholder meeting9 slidesMay 12, 2022
Investor Presentation (March 2022)Investor deck20 slidesMar 14, 2022
Investor Presentation (February 2022)Investor deck21 slidesFeb 2, 2022

Open Decks

Financings

RaiseDateIn US dollars
Private placement of cHESS Depositary Interests (CDIs)
Closed: A$35M raised · A$0.38 a share
Aug 25, 2026US$25.05M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023
Revenue1.62M
Cost of revenue1.13M
Gross profit490.0K
Research and development23.9M27.1M27.1M
Operating income-46.1M-38.3M-34.5M
Depreciation and amortization403.0K587.0K752.3K
EBITDA-45.7M-37.7M-33.8M
Interest expense5.64M6.03M4.48M
Income before tax-48.8M-40.8M-35.0M
Income tax2.00K2.00K1.63K
Net income-48.8M-40.8M-35.0M
Earnings per share, basic-0.12-0.13-0.12
Earnings per share, diluted-0.12-0.13-0.12

Balance sheet

LineFY2025FY2024FY2023
Cash and equivalents5.79M6.92M14.6M
Short-term investments47.4M53.7M57.7M
Inventory13.8M1.39M0
Current assets73.1M64.5M74.4M
Property, plant and equipment5.48M795.0K1.09M
Total assets97.2M73.6M78.9M
Accounts payable7.05M3.25M1.86M
Current liabilities14.0M8.33M6.45M
Total debt41.8M41.8M
Total liabilities71.6M49.2M47.8M
Shareholders' equity25.6M24.4M31.1M
Shares outstanding45.0M371.1M307.0M

Cash flow

LineFY2025FY2024FY2023
Cash from operations-53.2M-41.2M-32.7M
Capital spending-3.68M-273.0K-354.1K
Free cash flow-56.9M-41.5M-33.1M
Cash from investing7.84M1.11M-8.64M
Cash from financing46.8M32.5M40.5M
Change in cash1.48M-7.66M-877.6K

Open Financials

Filings

FilingDateTypeFiled with
CMS Proposes National Medicare Coverage for WiSE SystemNov 19, 2026Operations updateASX
4 · Change in ownershipNov 16, 2026Insider tradeSEC
Change of Director's Interest NoticeNov 15, 2026Ownership change noticeASX
Customers Notification - Updated Ultrasound PrecautionsNov 11, 2026Other filingsASX
Investor WebinarNov 9, 2026Meeting noticeASX
Q3 2026 Quarterly Activity Report and Form 10-Q SubmissionNov 9, 2026Other filingsASX
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
EBR to Present at Canaccord Genuity ForumNov 2, 2026Other filingsASX
SCHEDULE 13G/A · Big-stake notice, amendedNov 2, 2026Big-stake noticeSEC
Notification of cessation of securities - EBROct 19, 2026FinancingASX
All 159 filings
FilingDateTypeFiled with
EBR Submits TGA ARTG Application for WiSE SystemOct 19, 2026Operations updateASX
EBR Submits TGA ARTG Application for WiSE SystemOct 19, 2026Operations updateASX
Notification regarding unquoted securities - EBROct 18, 2026Other filingsASX
EBR Systems to Participate in 19th APHRS 2026Oct 18, 2026Operations updateASX
Amended Appointment of Chief Medical OfficerOct 15, 2026Management or board changeASX
Application for quotation of securities - EBROct 15, 2026FinancingASX
Appointment of Chief Medical OfficerOct 15, 2026Management or board changeASX
Q3 2026 Commercial UpdateOct 11, 2026Other filingsASX
Completion of FDA Inspection of New Manufacturing FacilitySep 27, 2026Operations updateASX
Upcoming Australian Investor ConferencesSep 23, 2026Other filingsASX
Substantial Holding NotificationSep 22, 2026Ownership change noticeASX
CMS Finalises Increased Inpatient Reimbursement for WiSESep 20, 2026Operations updateASX
EBR FDA Plan for Addressing Echo-induced Pacing RisksSep 15, 2026Operations updateASX
FDA Initiates Inspection of New Manufacturing FacilitySep 14, 2026Operations updateASX
Investor RoadshowSep 8, 2026Other filingsASX
Update on FDA Review of Cybersecurity IncidentSep 8, 2026Operations updateASX
New Manufacturing Facility Achieves ISO CertificationSep 6, 2026Operations updateASX
SCHEDULE 13G/A · Big-stake notice, amendedAug 25, 2026Big-stake noticeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
Cleansing NoticeAug 24, 2026FinancingASX
Application for quotation of securities - EBRAug 24, 2026FinancingASX
Form S-8 Registration StatementAug 24, 2026Other filingsASX
S-8 · Registration statement for employee plansAug 24, 2026Offer documentSEC
8-K · Current reportAug 24, 2026Management or board changeSEC
Transition of Chief Commercial OfficerAug 20, 2026Management or board changeASX
8-K · Current reportAug 20, 2026Meeting outcomeSEC
Results of MeetingAug 18, 2026Meeting outcomeASX
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
Q2 2026 Quarterly Activity Report and Form 10-Q SubmissionAug 11, 2026Other filingsASX
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
EBR to Attend Canaccord 46th Annual Growth ConferenceAug 3, 2026Other filingsASX
Investor Webinar PresentationJul 30, 2026Other filingsASX
Additional Information Regarding Recent ReportsJul 30, 2026Operations updateASX
Q2 2026 Progress in WiSE Commercial RolloutJul 29, 2026Other filingsASX
Investor WebinarJul 28, 2026Notification letterASX
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJul 9, 2026Meeting noticeSEC
DEF 14A · Proxy statementJul 9, 2026Meeting noticeSEC
3 · Initial statement of ownershipJul 8, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 7, 2026Big-stake noticeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 6, 2026Big-stake noticeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 1, 2026Insider tradeSEC
PRE 14A · Preliminary proxy statementJun 29, 2026Meeting noticeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
8-K · Current reportJun 10, 2026Material contractSEC
10-Q · Quarterly reportMay 11, 2026Quarterly reportSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
8-K · Current reportMay 7, 2026Meeting outcomeSEC
8-K · Current reportApr 8, 2026ResultsSEC
ARS/A · Annual report to shareholders, amendedMar 30, 2026Annual reportSEC
8-K · Current reportMar 26, 2026Current reportSEC
ARS · Annual report to shareholdersMar 26, 2026Annual reportSEC
DEFA14A · Additional proxy materialMar 26, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 26, 2026Meeting noticeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
10-K · Annual reportMar 18, 2026Annual reportSEC
PRE 14A · Preliminary proxy statementMar 16, 2026Meeting noticeSEC
8-K · Current reportMar 13, 2026Meeting outcomeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJan 26, 2026Meeting noticeSEC
DEF 14A · Proxy statementJan 26, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 16, 2026Meeting noticeSEC
8-K · Current reportJan 13, 2026ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2025Big-stake noticeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
8-K · Current reportMay 29, 2025Material contractSEC
3/A · Initial statement of ownership, amendedMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
8-K · Current reportMay 22, 2025Meeting outcomeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
3/A · Initial statement of ownership, amendedMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportApr 15, 2025Current reportSEC
8-K · Current reportApr 14, 2025Current reportSEC
ARS · Annual report to shareholdersApr 11, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 11, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 11, 2025Meeting noticeSEC
3 · Initial statement of ownershipApr 1, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementApr 1, 2025Meeting noticeSEC
10-K · Annual reportMar 24, 2025Annual reportSEC
8-K · Current reportMar 20, 2025Current reportSEC
UPLOAD · Letter from the SECJan 28, 2025Other filingsSEC
CORRESP · Letter to the SECJan 21, 2025Other filingsSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
UPLOAD · Letter from the SECDec 23, 2024Other filingsSEC
CORRESP · Letter to the SECDec 17, 2024Other filingsSEC
SC 13G · Big-stake noticeDec 4, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECDec 3, 2024Other filingsSEC
SC 13G · Big-stake noticeNov 26, 2024Big-stake noticeSEC
4 · Change in ownershipNov 26, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 26, 2024Insider tradeSEC
SC 13G · Big-stake noticeNov 26, 2024Big-stake noticeSEC
10-12G/ANov 20, 2024Other filingsSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
UPLOAD · Letter from the SECNov 7, 2024Other filingsSEC
S-8 · Registration statement for employee plansOct 28, 2024Offer documentSEC
10-12G/AOct 22, 2024Other filingsSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 15, 2024Insider tradeSEC
UPLOAD · Letter from the SECOct 7, 2024Other filingsSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
10-12G/ASep 17, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 26, 2024Other filingsSEC
10-12GJul 29, 2024Other filingsSEC
DJul 12, 2021Other filingsSEC
DOct 7, 2019Other filingsSEC
DNov 16, 2017Other filingsSEC
DJul 15, 2014Other filingsSEC
DFeb 10, 2011Other filingsSEC
REGDEXDec 21, 2005Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from EBR Systems, Inc.’s releases · as of Aug 25, 2026

Common shares
753,355,590
Fully diluted
753,355,590

Fully diluted

LineShares
Common shares753,355,590

Share count over time

CountShares
Nov 22, 2026753,355,590

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Bronwyn EVANS
Director
Buy572,630AUD 0.17AUD 94,484Nov 12, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Karen Drexler
Other companies: Outset Medical, Inc. (Director · Since at least Jan 8, 2021); ResMed Inc. (Director · Since at least Nov 16, 2017); Valion Bio, Inc. (Director · Nov 10, 2021 – Sep 30, 2024 · Past)
Director · Since at least Sep 30, 2024
Allan R Will
Other companies: Fractyl Health, Inc. (Director · Feb 1, 2024 – Feb 1, 2024 · Past)
Director · Since at least Sep 30, 2024
Trevor J Moody
Other companies: electroCore, Inc. (Director · Jun 21, 2018 – Aug 2, 2023 · Past)
Director · Since at least Sep 30, 2024
Bronwyn EvansDirector · Since at least Sep 30, 2024
Christopher NaveDirector · Since at least Sep 30, 2024
David SteinhausDirector · Since at least Sep 30, 2024
Erik StrandbergChief Commercial Officer · Since at least Mar 24, 2025
Gary W DohertyChief Financial Officer · Since at least Sep 30, 2024
John McCutcheonPresident and CEO, Director · Since at least Sep 30, 2024
John SmithCEO · Since at least Nov 4, 2026
All 15 people
PersonSeat
Michael HendricksenChief Operating Officer · Since at least Sep 30, 2024
Robert C. CanbyChief Medical Officer · Since at least Oct 16, 2026
Santa ClaraEBR announces transition of Chief Commercial Officer · Since at least Aug 20, 2026
Sara HardinProject Manager · Since at least Nov 4, 2026
Simon AdamsCTO · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about EBR Systems, Inc.